Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
UBS Group AG has become a substantial holder of Australian Clinical Labs Ltd, acquiring a 6.21% voting power through various branches and subsidiaries. This move involves over 12.5 million ordinary shares, highlighting UBS’s strategic interest in the company. Investors may find this development noteworthy as it reflects a significant financial stake by a major global player.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.